Skip to content
Intravacc
IntravaccIntravacc
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research
Contact
Search:
  • Publications
    • Scientific Publications
    • Vaccsheets
    • Annual report
  • Events
  • News
  • Career
  • Partnering
  • About us
    • Company profile
    • Board of Directors
    • Management Team
    • Supervisory Board
    • Scientific advisory board
  • Services
    • Vaccine development
      • Process development
        • Upstream processing
        • Downstream processing
        • Formulation
      • Vaccine strain design
      • GMP
    • Assays
      • Analytical method development
  • Platforms
    • Cell based platform
    • OMV Platform
    • Conjugate vaccines
  • Products
  • 3R Research

09/10/2020

You are here:
  1. Home
  2. 2020
  3. October
  4. 09

Physicochemical and immunochemical assays for monitoring consistent production of tetanus toxoid

3R ResearchBy Mirjam Hartman09/10/2020

Regulatory acceptance and use of 3R models for pharmaceuticals and chemicals: expert opinions on the state of affairs and the way forward

3R ResearchBy Mirjam Hartman09/10/2020

Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers

3R ResearchBy Mirjam Hartman09/10/2020

Regulatory acceptance and use of serology for inactivated veterinary rabies vaccines

3R ResearchBy Mirjam Hartman09/10/2020

Erratum: Regulatory Acceptance and Use of Serology for Inactivated Veterinary Rabies Vaccines

3R ResearchBy Mirjam Hartman09/10/2020

In vitro innate immune cell based models to assess whole cell Bordetella pertussis vaccine quality: a proof of principle

3R ResearchBy Mirjam Hartman09/10/2020

The European Partnership for Alternative Approaches to Animal Testing (EPAA): promoting alternative methods in Europe and beyond

3R ResearchBy Mirjam Hartman09/10/2020

Alternatives to HIST for acellular pertussis vaccines: progress and challenges in replacement

3R ResearchBy Mirjam Hartman09/10/2020

In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?

3R ResearchBy Mirjam Hartman09/10/2020

Reporter cell lines for detection of pertussis toxin in acellular pertussis vaccines as a functional animal-free alternative to the in vivo histamine sensitization test

3R ResearchBy Mirjam Hartman09/10/2020
→12345…
6789
10→

Copyright © 2018 Intravacc - Privacy & Disclaimer

ISO Certifications: ISO 14001

Go to Top

We gebruiken cookies om u de beste ervaring op onze website te bieden. U kunt meer te weten komen over welke cookies we gebruiken of ze uitschakelen in instellingen .

Intravacc
Privacy overzicht

Deze website maakt gebruik van cookies zodat we u de best mogelijke gebruikerservaring kunnen bieden. Cookie-informatie wordt opgeslagen in uw browser en voert functies uit zoals u herkennen wanneer u terugkeert naar onze website en ons team helpen begrijpen welke delen van de website u het meest interessant en nuttig vindt.

Strikt noodzakelijke cookies

Strikt noodzakelijke cookies moeten te allen tijde zijn ingeschakeld, zodat we uw voorkeuren voor cookie-instellingen kunnen opslaan.

Als u deze cookie uitschakelt, kunnen we uw voorkeuren niet opslaan. Dit betekent dat u elke keer dat u deze website bezoekt, cookies opnieuw moet in- of uitschakelen.